[Systemic chemotherapy with high-dose cisplatin and sodium thiosulfate rescue]. 1985

K Lee, and T Kubota, and F Yoshimine, and M Sawamura, and K Tsuchimoto, and H Toyoda, and T Miyagawa, and E Kobayashi, and K Kadowaki, and E Kawamura

Intravenous bolus injection of an 80- to 120-mg/m2 dose of cisplatin followed by "rescue" with sodium thiosulfate (STS) was tried in the treatment of 7 patients with advanced tumor. STS was given continuously i.v. six hours after cisplatin injection, combined with methylprednisolone and metoclopramide as antiemetics. Four patients were evaluable, consisting of one CR, one PR and two NC. Severe nausea and emesis occurred in two patients and irreversible renal dysfunction occurred in one. The clinical use of the STS rescue regimen was discussed in conjunction with our basic investigation of "STS-rescue" in an animal model.

UI MeSH Term Description Entries
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D008080 Liposarcoma A malignant tumor derived from primitive or embryonal lipoblastic cells. It may be composed of well-differentiated fat cells or may be dedifferentiated: myxoid (LIPOSARCOMA, MYXOID), round-celled, or pleomorphic, usually in association with a rich network of capillaries. Recurrences are common and dedifferentiated liposarcomas metastasize to the lungs or serosal surfaces. (From Dorland, 27th ed; Stedman, 25th ed) Liposarcoma, Dedifferentiated,Liposarcoma, Pleomorphic,Atypical Lipomatous Tumor,Liposarcoma, Well Differentiated,Well Differentiated Liposarcoma,Atypical Lipomatous Tumors,Dedifferentiated Liposarcoma,Dedifferentiated Liposarcomas,Lipomatous Tumor, Atypical,Liposarcomas,Pleomorphic Liposarcoma,Pleomorphic Liposarcomas,Well Differentiated Liposarcomas
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001749 Urinary Bladder Neoplasms Tumors or cancer of the URINARY BLADDER. Bladder Cancer,Bladder Neoplasms,Cancer of Bladder,Bladder Tumors,Cancer of the Bladder,Malignant Tumor of Urinary Bladder,Neoplasms, Bladder,Urinary Bladder Cancer,Bladder Cancers,Bladder Neoplasm,Bladder Tumor,Cancer, Bladder,Cancer, Urinary Bladder,Neoplasm, Bladder,Neoplasm, Urinary Bladder,Tumor, Bladder,Tumors, Bladder,Urinary Bladder Neoplasm
D001859 Bone Neoplasms Tumors or cancer located in bone tissue or specific BONES. Bone Cancer,Cancer of Bone,Cancer of the Bone,Neoplasms, Bone,Bone Neoplasm,Neoplasm, Bone
D002276 Carcinoid Tumor A usually small, slow-growing neoplasm composed of islands of rounded, oxyphilic, or spindle-shaped cells of medium size, with moderately small vesicular nuclei, and covered by intact mucosa with a yellow cut surface. The tumor can occur anywhere in the gastrointestinal tract (and in the lungs and other sites); approximately 90% arise in the appendix. It is now established that these tumors are of neuroendocrine origin and derive from a primitive stem cell. (From Stedman, 25th ed & Holland et al., Cancer Medicine, 3d ed, p1182) Argentaffinoma,Carcinoid,Carcinoid, Goblet Cell,Argentaffinomas,Carcinoid Tumors,Carcinoids,Carcinoids, Goblet Cell,Goblet Cell Carcinoid,Goblet Cell Carcinoids,Tumor, Carcinoid,Tumors, Carcinoid
D002945 Cisplatin An inorganic and water-soluble platinum complex. After undergoing hydrolysis, it reacts with DNA to produce both intra and interstrand crosslinks. These crosslinks appear to impair replication and transcription of DNA. The cytotoxicity of cisplatin correlates with cellular arrest in the G2 phase of the cell cycle. Platinum Diamminodichloride,cis-Diamminedichloroplatinum(II),cis-Dichlorodiammineplatinum(II),Biocisplatinum,Dichlorodiammineplatinum,NSC-119875,Platidiam,Platino,Platinol,cis-Diamminedichloroplatinum,cis-Platinum,Diamminodichloride, Platinum,cis Diamminedichloroplatinum,cis Platinum
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug

Related Publications

K Lee, and T Kubota, and F Yoshimine, and M Sawamura, and K Tsuchimoto, and H Toyoda, and T Miyagawa, and E Kobayashi, and K Kadowaki, and E Kawamura
February 1985, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
K Lee, and T Kubota, and F Yoshimine, and M Sawamura, and K Tsuchimoto, and H Toyoda, and T Miyagawa, and E Kobayashi, and K Kadowaki, and E Kawamura
June 1985, Nihon Hinyokika Gakkai zasshi. The japanese journal of urology,
K Lee, and T Kubota, and F Yoshimine, and M Sawamura, and K Tsuchimoto, and H Toyoda, and T Miyagawa, and E Kobayashi, and K Kadowaki, and E Kawamura
January 1990, Critical reviews in oncology/hematology,
K Lee, and T Kubota, and F Yoshimine, and M Sawamura, and K Tsuchimoto, and H Toyoda, and T Miyagawa, and E Kobayashi, and K Kadowaki, and E Kawamura
October 1986, American journal of clinical oncology,
K Lee, and T Kubota, and F Yoshimine, and M Sawamura, and K Tsuchimoto, and H Toyoda, and T Miyagawa, and E Kobayashi, and K Kadowaki, and E Kawamura
January 1991, Journal of cancer research and clinical oncology,
K Lee, and T Kubota, and F Yoshimine, and M Sawamura, and K Tsuchimoto, and H Toyoda, and T Miyagawa, and E Kobayashi, and K Kadowaki, and E Kawamura
November 1984, Cancer treatment reports,
K Lee, and T Kubota, and F Yoshimine, and M Sawamura, and K Tsuchimoto, and H Toyoda, and T Miyagawa, and E Kobayashi, and K Kadowaki, and E Kawamura
December 1982, Annals of internal medicine,
K Lee, and T Kubota, and F Yoshimine, and M Sawamura, and K Tsuchimoto, and H Toyoda, and T Miyagawa, and E Kobayashi, and K Kadowaki, and E Kawamura
January 1988, Acta oncologica (Stockholm, Sweden),
K Lee, and T Kubota, and F Yoshimine, and M Sawamura, and K Tsuchimoto, and H Toyoda, and T Miyagawa, and E Kobayashi, and K Kadowaki, and E Kawamura
September 1985, European journal of cancer & clinical oncology,
K Lee, and T Kubota, and F Yoshimine, and M Sawamura, and K Tsuchimoto, and H Toyoda, and T Miyagawa, and E Kobayashi, and K Kadowaki, and E Kawamura
November 1991, Gynecologic oncology,
Copied contents to your clipboard!